UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial

Annals of oncology, 2018-11, Vol.29 (11), p.2247-2253

2018

Volltextzugriff (PDF)

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

British journal of cancer, 2012-08, Vol.107 (4), p.604-611

2012

Volltextzugriff (PDF)

Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3503-3511

1999

Volltextzugriff (PDF)

Multicenter Phase I-II Trial of Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy for Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1096-1104

2001

Volltextzugriff (PDF)

Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy

Annals of oncology, 2017-02, Vol.28 (2), p.415-420

2017

Volltextzugriff (PDF)

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1331-1339

1998

Volltextzugriff (PDF)

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

Seminars in radiation oncology, 2003-07, Vol.13 (3), p.176-181

2003

Volltextzugriff (PDF)

Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)

American journal of clinical oncology, 2002-04, Vol.25 (2), p.153-159

2002

Volltextzugriff (PDF)

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

The New England journal of medicine, 2016-11, Vol.375 (19), p.1856-1867

2016

Volltextzugriff (PDF)

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

The New England journal of medicine, 2016-11, Vol.375 (19), p.1856-1867

2016

Volltextzugriff (PDF)

The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck

Seminars in oncology, 2000-08, Vol.27 (4 Suppl 8), p.13

2000

Volltextzugriff (PDF)

A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck

Annals of oncology, 2000-05, Vol.11 (5), p.535-539

2000

Volltextzugriff (PDF)

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results

Journal of clinical oncology, 1997-09, Vol.15 (9), p.3100-3110

1997

Volltextzugriff (PDF)

NCCN Practice Guidelines for Head and Neck Cancers

Oncology (Williston Park, N.Y.), 2000-11, Vol.14 (11A), p.163

2000

Volltextzugriff (PDF)

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies

International journal of radiation oncology, biology, physics, 1999-03, Vol.43 (5), p.1001-1008

1999

Volltextzugriff (PDF)

Docetaxel in head and neck cancer: A review

American journal of clinical oncology, 1998-10, Vol.21 (5), p.482-486

1998

Volltextzugriff (PDF)

Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.599-604

2001

Volltextzugriff (PDF)

The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6098-6098

2004

Volltextzugriff (PDF)

Post-Treatment FDG-PET/CT Hopkins Criteria Predict Locoregional Recurrence After Definitive Radiotherapy for Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e399-e399

2021

Volltextzugriff (PDF)

Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550)

Oncology (Williston Park, N.Y.), 2001-09, Vol.15 (9), p.1168-1169

2001

Volltextzugriff (PDF)

Development of Investigational Radiation Modifiers

JNCI : Journal of the National Cancer Institute, 2003-05, Vol.95 (9), p.646-651

2003

Volltextzugriff (PDF)

Re: "Sialadenosis: a presenting sign in Bulemia" (Head and Neck 20: 758-762, 1998)

Head & neck, 1999-09, Vol.21 (6), p.582-582

Colevas, A D

1999

Volltextzugriff (PDF)

Intramucosal spread of malignant melanoma of the oral cavity

Otolaryngology-head and neck surgery, 1998-12, Vol.119 (6), p.711-711

1998

Volltextzugriff (PDF)

Hearing evaluation of head and neck cancer patients (HNCP): Comparison of CTCAE, Brock and Chang adverse event (AE) criteria in patients receiving cisplatin (CDDP)

Head & neck, 2014-07, Vol.37 (8), p.1102-1107

2014

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(154)

Publikationsform

Artikel
(173)
Buchkapitel
(4)

Sprache

Englisch
(177)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(72)
Science & Technology
(72)
Life Sciences & Biomedicine
(70)
Oncology
(56)
Male
(46)
Female
(42)
Middle Aged
(42)
Aged
(41)
Adult
(36)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Pharmacology. Drug Treatments
(23)
Antineoplastic Agents
(22)
Head And Neck Neoplasms - Drug Therapy
(21)
Tumors
(20)
Aged, 80 And Over
(18)
Chemotherapy
(18)
Head And Neck Neoplasms - Pathology
(18)
Carcinoma, Squamous Cell - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck

Multicenter Phase I-II Trial of Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy for Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck

Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck

A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results

NCCN Practice Guidelines for Head and Neck Cancers

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies

Docetaxel in head and neck cancer: A review

Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck

The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials

Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial

Post-Treatment FDG-PET/CT Hopkins Criteria Predict Locoregional Recurrence After Definitive Radiotherapy for Oropharyngeal Squamous Cell Carcinoma

Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550)

Development of Investigational Radiation Modifiers

Re: "Sialadenosis: a presenting sign in Bulemia" (Head and Neck 20: 758-762, 1998)

Intramucosal spread of malignant melanoma of the oral cavity

Hearing evaluation of head and neck cancer patients (HNCP): Comparison of CTCAE, Brock and Chang adverse event (AE) criteria in patients receiving cisplatin (CDDP)

Suchergebnisse filtern